New aspects of gliatilin’ application for treating of patients with mild cognitive impairment
The term «MCI» (MCI) denote the condition characterized by disturbance, at least one of the characteristics of cognitive sphere, it does not lead to the violation of autonomy in daily life, so it created the modern concept of mild cognitive decline «mild cognitive impairment» (MCI) identificeret cat...
Saved in:
Main Authors: | S. M. Moroz, A. G. Kirichenko, I. V. Rozhkova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation
2018-07-01
|
Series: | Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева |
Subjects: | |
Online Access: | https://www.bekhterevreview.com/jour/article/view/34 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of cognitive impairment in the early postoperative period
by: L. V. Roshkovskaya, et al.
Published: (2018-07-01) -
Gliatilin in the treatment of patients in the recovery period of cerebral stroke
by: V. N. Mishchenko, et al.
Published: (2018-07-01) -
Affective post-stroke disorders: pathogenesis, diagnosis, treatment
by: V. A. Mikhailov, et al.
Published: (2018-07-01) -
Prediction for vascular mild cognitive impairment using the p300 event-related potentials technique
by: Yu. V. Sturova, et al.
Published: (2014-10-01) -
Choline Alphoscerat (Gliatilin) in the pathogenetic therapy of Alzheimer’s disease
by: D. V. Zaharov, et al.
Published: (2019-02-01)